Skip to Content

Uncategorized Document

Notice of Intent To Grant an Exclusive License

Document Details

Information about this document as published in the Federal Register.

Enhanced Content

Relevant information about this document from Regulations.gov provides additional context. This information is not part of the official Federal Register document.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Office of Research and Development, Department of Veterans Affairs.

ACTION:

Notice of Intent.

SUMMARY:

Notice is hereby given that the Department of Veterans Affairs (VA), Office of Research and Development (ORD), intends to grant to Primorigen Biosciences, Inc., 510 Charmany Drive, Madison, WI 53719, USA, an exclusive license to practice the following: U.S. Patent Application Serial No. 13/225,441 and PCT Application Number PCT/US11/50462, “Efficient Generation of Neurally-Induced Mesenchymal Stem Cells and Applications Thereof,” filed September 3, 2011, and any subsequent non-provisional patent application(s) that will claim the benefit of U.S. Patent Application Serial No. 13/225,441 and PCT Application Number PCT/US11/50462, “Efficient Generation of Neurally-Induced Mesenchymal Stem Cells and Applications Thereof.”

DATES:

Comments must be received within 15 days from the date of this published Notice.

ADDRESSES:

Written comments may be submitted through www.regulations.gov by mail or hand-delivery to the Director, Regulations Management (02REG), Department of Veterans Affairs, 810 Vermont Avenue NW, Room 1068, Washington, DC 20420; or by fax to (202) 273-9026. Copies of comments received will be available for public inspection in the Office of Regulation Policy and Management, Room 1063B, between the hours of 8:00 a.m. and 4:30 p.m., Monday through Friday (except holidays). Call (202) 461-4902 for an appointment (This is not a toll-free number). In addition, during the comment period, comments may be viewed online through the Federal Docket Management System at http://www.regulations.gov.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Director of Technology Transfer Program, Office of Research and Development (10P9TT), Department of Veterans Affairs, 810 Vermont Avenue NW., Washington, DC 20420, (202) 443-5640 (This is not a toll-free number).

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

It is in the public interest to license this invention, as Primorigen Biosciences, Inc. submitted a complete and sufficient application for a license. The prospective exclusive license will be royalty-bearing and will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license may be granted, unless VA ORD receives written evidence and argument within 15 days from the date of this published Notice, which establishes that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7.

Start Signature

Dated: December 31, 2013.

Jose D. Riojas,

Chief of Staff, Department of Veterans Affairs.

End Signature End Supplemental Information

[FR Doc. 2014-00048 Filed 1-6-14; 8:45 am]

BILLING CODE 8320-01-P